Award
Delivery Order #SPE2DR26FMJY2
Pharmaceutical Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$25.50
Ceiling
$25.50
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FMJY2
NAICS
424210
This award represents a delivery order contract issued under an existing indefinite delivery vehicle (IDV) to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical services. The contract focuses on procuring Midazolam Hydrochloride, an important pharmaceutical product used in medical treatments. The delivery order is part of a broader multi-year IDV contract which supports pharmaceutical supply needs for healthcare operations. The work includes timely delivery of the specified drug within a short, well-defined timeframe. This order was competitively awarded as part of the parent IDV, reflecting an ongoing relationship underpinning efficient pharmaceutical supply. The contract's swift delivery timeline provides critical support to the agency's healthcare provisioning efforts, ensuring availability of essential medications. The performance period is a brief window in early 2026, reflecting the delivery's focused scope within the larger contract structure.
Description
4571140582! MIDAZOLAM HYDROCHLORI